SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CIPLA

BSE: 500087 22 May 2025
Healthcare
₹ 1467.3
Cipla Ltd., specializes in Pharmaceuticals within the Healthcare sector.

CIPLA - Share Price & Details

Market Cap
₹1,18,848
High /Low
1,702 / 1,310
Stock P/E
22.5
Book Value
₹386.0
Dividend Yield
0.88
ROCE
23.3
ROE
₹18.2
Face Value
2.0
PEG Ratio
0.75
EVEBITDA
₹14.8
Debt
438
CMP / FCF
42.4
Debt to equity
₹0.01
NP Ann
5,269
High price all time
1,702
Piotroski score
₹6.0
Graham Number
753.0
No. Eq. Shares
80.8
Net CF
₹21.0
Net profit
5,269
Price to book value
3.84
Interest Coverage
₹111.0
Low price all time
84.7
Industry PE
32.1
Reserves
₹31,032
Free Cash Flow
₹3,490

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic0.700.190.61NA4.1732.1
Triochem Products Ltd.,4.590.88NA3.600
CIPLA LTD.70191.512141.467296.915.121,18,84822.5
Max Healthcare Institute Limit7568.51773.96587.01.8111047997.6
TORRENT PHARMACEUTICALS LTD.24480.04740.024330.01410939956.8

Peer Comparison Chart


About CIPLA

Cipla Ltd.,, with Security Code 500087, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Cipla Arm to Procure Solar Power from AMPIN Energy Transition in Maharashtra

(21 May 2025)
Jay Precision Pharmaceuticals, a Cipla subsidiary, will source solar power from AMPIN Energy Transition. The company has signed a Share Purchase,...
Read more →

Cipla Shares Gain 1.68% during today's trading session

(21 May 2025)
During today's trading session, Cipla's stock demonstrated a positive movement, rising by 1.68% to reach a price of Rs 1,478.80.
Read more →

Natco Pharma, Cipla, Other Pharma Stocks Surge Up To 4% As US Authorities Aim To Cut Drug Prices- News18

(21 May 2025)
Pharma stocks in India rallied on May 21 after the US announced efforts to implement an executive order aimed at reducing healthcare costs.
Read more →

Cipla arm to acquire 26% stake in AMPIN Energy C&I Eighteen

(20 May 2025)
Mumbai: Pharmaceutical giant Cipla Ltd. has announced that Jay Precision Pharmaceuticals Private Limited, a subsidiary of the Company,...
Read more →

Aiming to enter newer categories, generate revenue of Rs 1500 crores: Cipla Health

(20 May 2025)
Cipla Health aims for Rs. 1500 crore revenue by expanding into gut health and sexual wellness categories. CEO discusses growth strategies.
Read more →

Cipla shares fall more than 1.6% today amid high trading volume

(20 May 2025)
Despite the day's decline, Cipla's financial data and Very Bullish sentiment indicates underlying strength.
Read more →